SCHEMBL30946589

SCHEMBL30946589

O=[N+]([O-])c1cccc2c(/C=N/O)c[nH]c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNA2 P51530 1/20 0.52
▸ CASP6 P55212 1/20 0.52
▸ CTDSP1 Q9GZU7 1/20 0.52
▸ HPGD P15428 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ TDP1 Q9NUW8 2/20 0.47
▸ MAPT P10636 7/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ GAA P10253 3/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ SENP8 Q96LD8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27174908 1.00 DNA2 (0.52) DNA2CASP6CTDSP1HPGDHTT
SCHEMBL27174903 1.00 DNA2 (0.52) DNA2CASP6CTDSP1HPGDHTT
SCHEMBL3056048 0.82 TRIM24 (0.57) DNA2CASP6CTDSP1TDP1MAPT
SCHEMBL27566405 0.81 DNA2 (0.52) DNA2CASP6CTDSP1HPGDTDP1
SCHEMBL19651761 0.78 DNA2 (0.50) DNA2CASP6CTDSP1HPGDHTT
SCHEMBL22531806 0.75 CASP6 (0.47) DNA2CASP6CTDSP1HPGDHTT
SCHEMBL22531807 0.75 CASP6 (0.47) DNA2CASP6CTDSP1HPGDHTT
SCHEMBL27490067 0.74 KDM4E (0.59) DNA2CASP6CTDSP1HPGDHTT
SCHEMBL700769 0.73 CA12 (0.60) TDP1MAPTMEN1KMT2AGAA
SCHEMBL413681 0.73 CA12 (0.60) TDP1MAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4634155-A1 RBM39 SULFONAMIDE INHIBITORS Recursion Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
CN-119630658-A Heterocyclic RBM39 modulators 递归医药公司 2025-03-14 — — CN disclosed
WO-2024129634-A1 RBM39 SULFONAMIDE INHIBITORS RECURSION PHARMACEUTICALS, INC. (US) 2024-06-20 — — WO disclosed
Send feedback